Pharma-Bio Serv (PBSV) Non-Current Debt (2020 - 2021)
Pharma-Bio Serv's (PBSV) quarterly Non-Current Debt came in at $643900.0 in Q2 2021, down 50.0% YoY from $1.3 million in Q2 2020, and little changed on a QoQ basis from $643900.0 in Q1 2021.
Pharma-Bio Serv (PBSV) Non-Current Debt (2020 - 2021) Analysis & Trends
Pharma-Bio Serv (PBSV) has 2 years of Non-Current Debt data on file, last reported at $643900.0 in Q2 2021.
- Quarterly Non-Current Debt fell 50.0% year-over-year to $643900.0 in Q2 2021, while the trailing twelve-month figure through Apr 2021 was $643900.0 (down 50.0% YoY) and the FY2020 annual result came in at $643900.0, changed N/A from the prior year.
- Non-Current Debt held at $643900.0 in Q2 2021, from $643900.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $1.3 million in Q2 2020 to a low of $643900.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 2.15 Bn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 942.66 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | - |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 1.45 Bn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | - |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2021 | 643,900.00 |
| Jan 31, 2021 | 643,900.00 |
| Oct 31, 2020 | 643,900.00 |
| Jul 31, 2020 | 965,850.00 |
| Apr 30, 2020 | 1.29 Mn |